Early Cardiovascular Disease Detection: Ai Deep Learning Approach for Risk Stratification
DOI:
https://doi.org/10.63682/jns.v14i12S.3235Keywords:
Cardiovascular disease, AI, Deep learning, Risk stratification, Statistical analysis, Predictive modeling, Literature-based data.Abstract
Cardiovascular disease (CVD) remains one of the leading causes of morbidity and mortality worldwide, emphasizing the need for early detection and risk stratification. This study employs artificial intelligence (AI) and deep learning techniques to develop a predictive model for assessing CVD risk based on data extracted from existing literature. A systematic review was conducted to collect publicly available datasets from peer-reviewed studies, including demographic, clinical, and biomarker information relevant to CVD risk assessment.
A retrospective study design was utilized, where statistical and machine learning methodologies were applied to analyze pre-existing data. Feature selection was performed using logistic regression and principal component analysis (PCA) to identify the most significant predictors of CVD. A deep learning model incorporating convolutional neural networks (CNNs) and long short-term memory (LSTM) networks was trained on the extracted dataset. The model's performance was evaluated using accuracy, precision, recall, F1-score, and the area under the receiver operating characteristic curve (AUC-ROC). Comparative analysis with traditional statistical models, such as Cox proportional hazards regression and logistic regression, was conducted to assess the added value of AI-driven approaches.
Preliminary findings suggest that deep learning models achieve superior predictive performance compared to traditional statistical methods, with an AUC-ROC exceeding 0.90 in risk classification. These results highlight the potential of AI-driven risk stratification tools in enhancing early CVD detection. Future research should explore the clinical integration of such models to optimize patient outcomes.
Downloads
Metrics
References
Alhejaily, A. M. (2024). Artificial intelligence in healthcare (Review). Biomedical Reports, 22(1). https://pmc.ncbi.nlm.nih.gov/articles/PMC11582508/
Ejiyi, C. J., Qin, Z., Nneji, G. U., Monday, H. N., Agbes, V. K., Ejiyi, M. B., Bamisile, O. O. (2024). Enhanced Cardiovascular Disease Prediction Modelling using Machine Learning Techniques: A Focus on CardioVitalnet. Network: Computation in Neural Systems, 1-33. https://pubmed.ncbi.nlm.nih.gov/38626055/
Faizal, A. S., Thevarajah, T. M., Khor, S. M., & Chang, S. W. (2021). A review of risk prediction models in cardiovascular disease: conventional approach vs. artificial intelligent approach. Computer Methods and Programs in Biomedicine, 207, 106190. https://www.sciencedirect.com/science/article/abs/pii/S0169260721002649
Geethanjali, R., & Valarmathi, A. (2024). A novel hybrid deep learning IChOA-CNN-LSTM model for modality-enriched and multilingual emotion recognition in social media. Scientific Reports, 14(1). https://www.nature.com/articles/s41598-024-73452-2
LaBoone, P. A., & Marques, O. (2024). Overview of the future impact of wearables and artificial intelligence in healthcare workflows and technology. International Journal of Information Management Data Insights, 4(2), 100294. https://www.sciencedirect.com/science/article/pii/S2667096824000831
Lin, T., & Fan, M. (2024). Cardiovascular Disease Risk Prediction Based on Deep Feature Extraction. 9th International Conference on Intelligent Informatics and Biomedical Sciences (ICIIBMS), 9, 210-214. https://ieeexplore.ieee.org/abstract/document/10792830
Mienye, I. D., Swart, T. G., Obaido, G., Jordan, M., & Ilono, P. (2025). Deep Convolutional Neural Networks in Medical Image Analysis: A Review. Information, 16(3), 195. https://www.researchgate.net/publication/389523390_Deep_Convolutional_Neural_Networks_in_Medical_Image_Analysis_A_Review
Narkhede, S. (2018). Understanding auc-roc curve. Towards data science, 26(1), 220-227. https://www.48hours.ai/files/AUC.pdf
Salah, H., & Srinivas, S. (2022). Explainable machine learning framework for predicting long-term cardiovascular disease risk among adolescents. Scientific Reports, 12(1), 21905. https://www.nature.com/articles/s41598-022-25933-5
Schlesinger, D. E., & Stultz, C. M. (2020). Deep Learning for Cardiovascular Risk Stratification. Current Treatment Options in Cardiovascular Medicine, 22(8). https://link.springer.com/article/10.1007/s11936-020-00814-0
Shumailov, I., Shumaylov, Z., Zhao, Y., Papernot, N., Anderson, R., & Gal, Y. (2025). AI models collapse when trained on recursively generated data. Nature, 631(8022), 755-759. https://www.nature.com/articles/s41586-024-07566-y
Sofany, H. E., Bouallegue, B., & Latif, Y. M. (2024). A proposed technique for predicting heart disease using machine learning algorithms and an explainable AI method. Scientific Reports, 14(1), 1-18. https://www.nature.com/articles/s41598-024-74656-2
Teshale, A. B., Htun, H. L., Vered, M., Owen, A. J., Ryan, J., Tonkin, A., & Freak-Poli, R. (2024). Artificial intelligence improves risk prediction in cardiovascular disease. GeroScience, 1-6. https://pubmed.ncbi.nlm.nih.gov/39576563/
Vaduganathan, M., Mensah, G. A., Turco, J. V., Fuster, V., & Roth, G. A. (2022). The Global Burden of Cardiovascular Diseases and Risk: A Compass for Future Health. Journal of the American College of Cardiology, 80(25). https://www.jacc.org/doi/10.1016/j.jacc.2022.11.005
Varnosfaderani, S. M., & Forouzanfar, M. (2024). The Role of AI in Hospitals and Clinics: Transforming Healthcare in the 21st Century. Bioengineering, 11(4), 337. https://www.mdpi.com/2306-5354/11/4/337
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
